Key result
Presence of high-flow-mediated constriction was associated with significantly lower flow-mediated dilatation compared to non-H-FMC individuals (6.12% vs 8.09%; P<0.001).
Why the study?
Is high-flow-mediated constriction (H-FMC) associated with adverse cardiovascular and metabolic risk biomarkers and altered flow-mediated dilatation in adults?
Cross-Sectional (n=246)
Is high-flow-mediated constriction (H-FMC) associated with adverse cardiovascular and metabolic risk biomarkers and altered flow-mediated dilatation in adults?
Absolute Event Rate: 6.12% vs 8.09%
p-value: p=<0.001
High-flow-mediated constriction is associated with increased body mass and negatively affects the flow-mediated dilatation response, suggesting it should be accounted for when interpreting FMD data.
PURPOSE: During reactive hyperemia, the brachial artery in some individuals constricts prior to dilation. Our aim was to describe the frequency of high-flow-mediated constriction (H-FMC) in adults, and its relationship to body composition and biomarkers of cardiovascular and metabolic risk. METHODS: Two hundred forty-six adults (124 male, 122 female; 36 ± 7 years old) were assessed for H-FMC via sonographic imaging of the brachial artery. Blood pressure, glucose, insulin, lipids, and body composition assessed via dual energy X-ray absorptiometry were collected. H-FMC was characterized as a 10-second average of maximal postocclusion constriction. Independent t test was used to compare H-FMC versus non-H-FMC individuals. RESULTS: , p = 0.018), and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio (2.41 ± 1.03 versus 2.09 ± 0.72, p = 0.007) were higher in H-FMC than in non-H-FMC individuals. Flow-mediated dilatation (FMD) (6.12 ± 3.48 versus 8.09 ± 3.02%, p < 0.001) was lower in H-FMC subjects. However, there was no difference in brachial artery dilation between groups (7.57 ± 3.69 versus 8.09 ± 3.02%, p = 0.250) when H-FMC was added to FMD. CONCLUSIONS: Increased body mass, fat mass, and body mass index were associated with a greater H-FMC. When H-FMC was present, the FMD response to reactive hyperemia was significantly lower. Because H-FMC has been observed to negatively affect FMD response to reactive hyperemia, we suggest that H-FMC should be noted when analyzing and interpreting FMD data. H-FMC may be an ancillary measure of endothelial health.
No takes yet. Share an insight, caveat, or question.
Ostrem et al. (2016) conducted a cross-sectional in Adults (n=246). High-flow-mediated constriction (H-FMC) vs. Non-H-FMC was evaluated on Flow-mediated dilatation (FMD) (p=<0.001). Presence of high-flow-mediated constriction was associated with significantly lower flow-mediated dilatation compared to non-H-FMC individuals (6.12% vs 8.09%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: